Fidelity International’s Treace Medical Concepts TMCI Stock Holding History

Fidelity International’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-204,118	Closed	-$5.49M	–	856
2021 Q3	$5.49M	Sell	204,118 -80,812	-28%	-$2.22M	0.01%	591
2021 Q2	$8.91M	Buy	+284,930	New	+$9.07M	0.01%	570

Other funds holding TMCI

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Fidelity International's TMCI Position: Q4 2021 in Review

Fidelity International sold out of Treace Medical Concepts (TMCI) in Q4 2021, closing a stake of 204,118 shares — an estimated $5.49M sold.

Fidelity International first reported a position in TMCI in Q2 2021 and held it in 2 quarters. The position peaked at $8.91M in Q2 2021. 77 funds tracked by Wall St. Rank hold TMCI as of Q4 2021.

Fidelity International reported no remaining Treace Medical Concepts position as of Q4 2021 after selling out during the quarter.
Fidelity International sold 204,118 Treace Medical Concepts shares in Q4 2021, an estimated $5.49M.
Fidelity International first reported a position in Treace Medical Concepts in Q2 2021 and held it in 2 quarters.
Fidelity International's Treace Medical Concepts position peaked at $8.91M in Q2 2021.
77 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2021.

Based on Fidelity International's 13F filing for Q4 2021, filed 14 Feb 2022.